Treanda approved for chronic lymphocytic leukemia

Am J Health Syst Pharm. 2008 May 1;65(9):793. doi: 10.2146/news080034.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Bendamustine Hydrochloride
  • Drug Approval
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Nitrogen Mustard Compounds / administration & dosage
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • Bendamustine Hydrochloride